Synthesis of some thiazolyl and thiadiazolyl derivatives of 4(3H)-quinazolinone as anti-inflammatory-antimicrobial agents

Bollettino Chimico Farmaceutico

Volumn 143, Issue 1, 2004, Pages 34-39

  Bekhit, A A ^a   Habib, N S ^a   Park, Ji Young ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Sookmyung Women's University   (South Korea)

Author keywords

4(3H) Quinazolinone; Anti inflammatory and antimicrobial activities; Thiadiazole; Thiazole; Ulcerogenic effects

Indexed keywords

3 (4 METHYLPHENYL) 2 (4 OXOTHIAZOLIDIN 2 YLIDENEHYDRAZONOMETHYL) 4(3H) QUINAZOLINONE; 3 (4 METHYLPHENYL) 2 (PHENYL 2,3 DIHYDROTHIAZOL 2 YLIDENEHYDRAZONOMETHYL) 4(3H) QUINAZOLINONE; 3 (4 METHYLPHENYL) 2 [3 (THIOCARBAMOYLAMINO) 4 OXO 1,3 THIAZOLIDIN 2 YL] 4(3H) QUINAZOLINONE; 3 (4 METHYLPHENYL) 2 [3 ACETYL 5 (ACETAMIDO) 2,3 DIHYDRO 1,3,4 THIADIAZOL 2 YL] 4(3H) QUINAZOLINONE; 4(3H) QUINAZOLINONE DERIVATIVE; ACETIC ANHYDRIDE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; INDOMETACIN; THIACARBAMOYLHYDRAZONOMETHYL 4(3H) QUINAZOLINONE; THIADIAZOLINYL DERIVATIVE; THIAZOLINYL DERIVATIVE; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; NONSTEROID ANTIINFLAMMATORY AGENT; QUINAZOLINE DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CYCLIZATION; DRUG SYNTHESIS; HEATING; MALE; NONHUMAN; PAW EDEMA; RAT; REACTION ANALYSIS; ULCEROGENESIS; ANIMAL; BACTERIUM; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EDEMA; MICROBIOLOGICAL EXAMINATION; STOMACH ULCER; SYNTHESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIA; EDEMA; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; QUINAZOLINES; RATS; STOMACH ULCER; THIAZOLES;

EID: 2342644069     PISSN: 00066648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Farghaly A.M.; Bekhit A.A.; Park J.Y., Arch. Pharm. Pharm. Med. Chem. 2000, 333, 53.
2. Bekhit A. A. Abstracts-Alazhar 2nd International conference for Pharmaceutical and Biological Sciences, December 19-21, P. 34, Cairo, Egypt, 2001.
3. Bekhit A. A.; Fahmy H. T. Y.; Rostom Sh. A. E; Abdel-Aziem T. Abstracts-XXVIII International Conference of Pharmaceutical Sciences, P 81, Dec. 17-19, Cairo, Egypt, 2002.
4. Bekhit,A.A.; Fahmy, H.t.Y.; Rostom, Sh.A.F; Baraka, A. M., Eur. J. Med. Chem. 2003, 38, 27.
5. Bekhit A.A.; Fahmy, H.T.Y. Arch. Pharm. Pharm. Med. Chem. 2003, 33, 111.
6. Farghaly, A. M.; Chaaban, I; Khalil, M.A. and Bekhit, A.A., Arch. Pharm. 1990, 323, 311.
7. Farghaly, A. M.; Chaaban, I; Khalil, M.A. and Bekhit,A.A., Alex. J. Pharm. Sci. 1990, 4, 52.
8. Farghaly, A. M.; Chaaban, I; Khalil, M.A. and Bekhit, A.A., Arch. Pharm. 1990, 323,833.
9. Khalil M.A.; Soliman, R; Farghaly, A. M.; and Bekhit, A.A., Arch. Pharm. 1994 327, 27.
10. Bekhit, A.A. and Khalil, M.A., Pharmazie 1998, 53, 539.
11. Bekhit, A.A.; Habib, N. S. and Bekhit, A. E., Boll. Chim. Farmac., 2001, 140, 297.
12. Khalil, M.A., Alex. J. Pharm. Sci. 1989, 3, 221.
13. Farghaly, A.M.; Omar, A. Mohsen M. E.; Khalil, M.A.; Gaber, M.A. and Abou-Shleib, H., Eur. J. Med. Chem. 1987, 22, 369.
14. Di Rosa, M. and Willoughby, D.A., J. Pharm. Pharmcol. 1971, 23, 297..
15. Abou Zeit-Har, M.S.; Verimer, T. and Long, J.P., Pharmazie, 1982, 37, 593.
16. Murray P.R., Baron E.J., Pfaller M.A., Tenover F C., Yolken R. H., Manual of Clinical Microbiology, Woods G. L. and Washington J.A. (Eds), Antimicrobial Agents and Susceptibility Testing, Am. Soc. Microbiol., Washington, DC, 1995.